Action 603858 SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shandong Buchang Pharmaceuticals Co., Ltd.

Actions

603858

CNE100002FV6

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 11/06/2024 		Varia. 5j. Varia. 1 janv.
15,17 CNY +0,26 % Graphique intraday de Shandong Buchang Pharmaceuticals Co., Ltd. -1,81 % -10,82 %
29/05 Shandong Buchang Pharmaceuticals obtient le feu vert de la Chine pour ses comprimes de controle du cholesterol MT
25/04 Shandong Buchang Pharmaceuticals Co. présente ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Shandong Buchang Pharmaceuticals Gets China Nod for Cholesterol Control Tablets
Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Shandong Buchang Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 14, 2023.
Buchang Pharma Obtains Green Light to Trial Gastric Cancer Drug Combination
Tranche Update on Shandong Buchang Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 14, 2023.
Buchang Pharma’s Drugs Retain National Medical Insurance Coverage
Shandong Buchang Pharmaceuticals Co., Ltd. announces an Equity Buyback for CNY 360 million worth of its shares.
Shandong Buchang Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
Buchang Pharma's Unit Gets Nod to Test Colorectal Cancer Drug
Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Haikou Xinyingyang Investment Partnership Enterprise (Limited Partnership) and Xi Chong agreed to acquire 14% stake in Buchang Health Industry (Zhejiang ) Co., Ltd. from Shandong Buchang Pharmaceuticals Co., Ltd.,Hu Cunchao, Li Hui, and Hu Cunchao for CNY 0.
Buchang Pharma Unit Gets Nod to Trial Cancer Treatment
Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Selling Expenses of Chinese Listed Pharma Companies About 1.5x Higher Than Net Profits in 2022
Buchang Pharmaceuticals to Set Up Medical Device Subsidiary
Buchang Pharma Unit Gets Nod to Make Amendments to Diabetes Drug
Buchang Pharmaceuticals to Invest 223 Million Yuan Into Old Factory Upgrade
Buchang Pharma's Unit Passes Regulator's Good Manufacturing Practice Evaluation
Zhao Yunhua agreed to acquire a 90% stake in Buchang Taoyiyun Health Technology Co., Ltd. from Shandong Buchang Pharmaceuticals Co., Ltd. for CNY 1.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 603858
  4. Actualités Shandong Buchang Pharmaceuticals Co., Ltd.
  5. Autres langues